Detalles de la búsqueda
1.
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.
Pediatr Allergy Immunol
; 35(5): e14131, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38700124
2.
COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain.
Pediatr Allergy Immunol
; 34(10): e14037, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37877845
3.
Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023.
Euro Surveill
; 28(49)2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38062942
4.
Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain.
Environ Res
; 215(Pt 2): 114252, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096168
5.
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
Lancet Infect Dis
; 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38701823
6.
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol.
Hum Vaccin Immunother
; 20(1): 2348135, 2024 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38738683
7.
Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons.
Arch Bronconeumol
; 59(8): 531-533, 2023 08.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-37003883
8.
Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons
Arch. bronconeumol. (Ed. impr.)
; 59(8): 531-533, ago. 2023. graf
Artículo
en Inglés
| IBECS (España) | ID: ibc-224095
Resultados
1 -
8
de 8
1
Próxima >
>>